Fintel reports that on October 13, 2025, JP Morgan Cazenove reiterated coverage of AstraZeneca PLC - Depositary Receipt (NasdaqGS:AZN) with a Overweight recommendation. Analyst Price Forecast Suggests ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration.

AstraZeneca announced a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a move that would ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

The president and top health officials acknowledged using the leverage of tariff threats to forge an agreement. Other ...

Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after ...

European governments will pay claims above an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official ...

Compared to the aggregate P/E ratio of the 82.48 in the Pharmaceuticals industry, AstraZeneca Inc. has a lower P/E ratio of ...